Long Term Arrhythmia Risk and Cardiovascular Events in Hematopoietic Stem Cell Transplant

CompletedOBSERVATIONAL
Enrollment

21

Participants

Timeline

Start Date

April 21, 2021

Primary Completion Date

June 17, 2024

Study Completion Date

June 17, 2024

Conditions
Hematopoietic Stem Cell TransplantAtrial FibrillationAtrial Flutter
Interventions
OTHER

HSCT Patients

Prospective, observational review of incidence of AF/AFL through Carelink remote monitoring and safety of implantation of device in this population of patients through review of standard of care follow up visits post HSCT implant

Trial Locations (1)

19104

Abramson Cancer Center at University of Pennsylvania, Philadelphia

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Medtronic

INDUSTRY

lead

Abramson Cancer Center at Penn Medicine

OTHER